Anzeige
Mehr »
Donnerstag, 11.12.2025 - Börsentäglich über 12.000 News
China zieht den Stecker - Lithiumpreis explodiert, Südamerika wird zum Gamechanger
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

NASDAQ Biotech 

WKN:  ISIN:  
Markt oder Branche auswählen:

Aktuelle News zu Aktien im NASDAQ Biotech

  • 24 h
  • 7 Tage
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache:  Alle DE EN
LeserMedien
02:18Cathie Wood's ARK sells Iridium stock, buys Nurix on Wednesday2
00:31Why Dyne Therapeutics Stock Was a Big Winner on Wednesday1
00:06Fortrea Holdings Inc: Fortrea Announces Grant of Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)1
Mi59 NORTH COMMUNICATIONS: Nanexa and Moderna enter into license and option agreement for the development of PharmaShell-based products3
MiCrinetics Pharmaceuticals, Inc.: Crinetics Pharmaceuticals Announces December 2025 Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)1
MiVera Therapeutics, Inc. - 8-K, Current Report-
MiRhythm Pharmaceuticals, Inc.: Rhythm Pharmaceuticals to Announce Preliminary Data from Exploratory Phase 2 Trial Evaluating Setmelanotide in Prader-Willi Syndrome2
MiBIONTECH SE ADR steht still - für mich das lauteste Signal!24
MiMirum Pharmaceuticals: Leerink hebt Kursziel auf 100 US-Dollar an2
MiMirum Pharmaceuticals stock price target raised to $100 by Leerink3
MiJefferies raises Olema Pharmaceuticals stock price target to $43 on SERD validation8
MiOmeros Corporation (OMER): Novo Nordisk Deal Creating Buzz107
MiVoyager Therapeutics (VYGR): Strong Q3 Prompts Bullish Coverage1
MiAscendis Pharma A/S - 6-K, Report of foreign issuer-
MiGALAPAGOS NV - S-8, Securities to be offered to employees in employee benefit plans1
MiAstraZeneca-, Gilead-backed program reduced side effects, distress in Black breast cancer patients: study4
MiRIGEL PHARMACEUTICALS INC - 8-K, Current Report-
Mi4D Molecular Therapeutics, Inc. - 8-K, Current Report-
MiNuvalent, Inc. - 8-K, Current Report-
MiDyne upgraded at Oppenheimer on upcoming trial readout from Avidity1
Weiter >>